These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8539318)

  • 1. Complex stimulus properties of LSD: a drug discrimination study with alpha 2-adrenoceptor agonists and antagonists.
    Marona-Lewicka D; Nichols DE
    Psychopharmacology (Berl); 1995 Aug; 120(4):384-91. PubMed ID: 8539318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus properties of clonidine: substitution by ergot derivatives.
    Cunningham KA; Callahan PM; Craigmyle NA; Appel JB
    Eur J Pharmacol; 1985 Dec; 119(3):225-9. PubMed ID: 2868902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD.
    Palumbo PA; Winter JC
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1221-6. PubMed ID: 1475306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of xylazine in rat: discriminability and effects of putative alpha-2 adrenoceptor agonists and antagonists.
    Colpaert FC; Janssen PA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):521-7. PubMed ID: 2865356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central alpha-2 adrenoceptors are responsible for a clonidine-induced cue in a rat drug discrimination paradigm.
    Jordan S; Jackson HC; Nutt DJ; Handley SL
    Psychopharmacology (Berl); 1993; 110(1-2):209-12. PubMed ID: 7870887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for noradrenergic involvement in mediating the FG 7142 discriminative stimulus.
    Leidenheimer NJ; Schechter MD
    Pharmacol Biochem Behav; 1992 Sep; 43(1):77-83. PubMed ID: 1357678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI.
    Marona-Lewicka D; Chemel BR; Nichols DE
    Psychopharmacology (Berl); 2009 Apr; 203(2):265-77. PubMed ID: 18604600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross generalization with LSD and yohimbine in the rat.
    Colpaert FC
    Eur J Pharmacol; 1984 Jul; 102(3-4):541-4. PubMed ID: 6489439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD).
    Cunningham KA; Appel JB
    Psychopharmacology (Berl); 1987; 91(1):67-73. PubMed ID: 3103161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide.
    Gresch PJ; Barrett RJ; Sanders-Bush E; Smith RL
    J Pharmacol Exp Ther; 2007 Feb; 320(2):662-9. PubMed ID: 17077317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenoceptors and dopamine receptors are not involved in the discriminative stimulus effect of the 5-HT1A receptor agonist flesinoxan.
    Ybema CE; Olivier B; Mos J; Tulp MT; Slangen JL
    Eur J Pharmacol; 1994 Apr; 256(2):141-7. PubMed ID: 8050464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 5-HT1A receptor and the stimulus effects of LSD in the rat.
    Reissig CJ; Eckler JR; Rabin RA; Winter JC
    Psychopharmacology (Berl); 2005 Oct; 182(2):197-204. PubMed ID: 16025319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives.
    Huang X; Marona-Lewicka D; Pfaff RC; Nichols DE
    Pharmacol Biochem Behav; 1994 Mar; 47(3):667-73. PubMed ID: 8208787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
    Marona-Lewicka D; Thisted RA; Nichols DE
    Psychopharmacology (Berl); 2005 Jul; 180(3):427-35. PubMed ID: 15723230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats.
    Popik P; Krawczyk M; Kuziak A; Bugno R; Hogendorf A; Staroń J; Nikiforuk A
    J Psychopharmacol; 2019 Nov; 33(11):1447-1455. PubMed ID: 31452444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus effects of the alpha 2-adrenoceptor antagonist idazoxan.
    Sanger DJ
    Psychopharmacology (Berl); 1989; 99(1):117-21. PubMed ID: 2571173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not alpha2-adrenoceptors.
    Powell SB; Palomo J; Carasso BS; Bakshi VP; Geyer MA
    Psychopharmacology (Berl); 2005 Jul; 180(3):491-500. PubMed ID: 15719216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.